Nephros, Inc. (NEPH) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Nephros, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.716 Good day and welcome to the Nefros, Inc. first quarter 2026 00:00:05.716 -- 00:00:11.181 financial results conference call. All participants will be in listen-only 00:00:11.181 -- 00:00:16.306 mode. Should you need assistance, please signal a conference specialist by pressing the 00:00:16.306 -- 00:00:21.430 star key followed by zero. After today's presentation, there will be 00:00:21.430 -- 00:00:26.675 an opportunity to ask questions. To ask a question, you may press star, 00:00:26.675 -- 00:00:31.846 then one on a touch-tone phone. To withdraw your question, please press star then 00:00:31.846 -- 00:00:35.812 two. Please note this event is being recorded. 00:00:35.812 -- 00:00:41.200 I would now like to turn the conference over to Karen Smith, Investor Relations. 00:00:41.200 -- 00:00:43.724 Please go ahead. 00:00:43.724 -- 00:00:47.838 Good afternoon, everyone. This is Karen Smith with PCG Advisory. 00:00:47.838 -- 00:00:52.403 Thank you all for participating in NEPHROES' first quarter 2026 00:00:52.403 -- 00:00:57.048 conference call. Before we begin, I would like to caution that comments made during this 00:00:57.048 -- 00:01:01.893 conference call by management will contain forward-looking statements regarding the operations 00:01:01.893 -- 00:01:06.478 and future results of NEPHROES. I encourage you to review NEPHROES' filings with the 00:01:06.478 -- 00:01:11.283 Securities and Exchange Commission, including, without limitation, Companies Forms 10-K 00:01:11.283 -- 00:01:16.329 and 10-Q. to identify specific factors that may cause actual results 00:01:16.329 -- 00:01:20.774 or events to differ materially from those described in the forward-looking statements. 00:01:20.774 -- 00:01:25.860 Factors that may affect the company...